Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Sor-C13 Tfa | 99.3% | 1565.81 (free acid) | 10 MG
Supplier: Medchemexpress LLC HYP1651A10MG
SOR-C13 TFA is a carboxy-terminal truncated peptide that acts as a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. It has shown anticancer activity and targets TRPV6, a non-voltage gated calcium channel associated with malignancy and poor prognosis in breast cancer.
- High-affinity TRPV6 antagonist
- Exhibits anticancer activity
- Targets non-voltage gated calcium channel TRPV6
- Potentially useful in breast cancer research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?